Global tuberculosis (TB) therapeutics market is projected to grow at a CAGR of over 4% during the forecast period. TB is one of the top 10 causes of global fatalities as it affects the lungs and causes life-threatening conditions in the human body. The primary factors that drive the growth of the market include the increased incidences of TB among the peoples, development of various drugs, along with government initiatives for promoting education concerning TB among the population. Further, increasing collaboration between academic and private players for novel drug development, and rising incidence of MDR and XDR cases in developing countries, are fuelling the growth of the market.

Get Free Sample Copy @ https://www.omrglobal.com/request-sample/tuberculosis-tb-therapeutics-market

However, certain factors such as lack of awareness about the disease diagnosis and treatment methods in various developing and under-developed countries such as Africa have been limiting the growth of the market. Moreover, increasing R&D activities for further advanced tuberculosis diagnostics will be the major opportunity for this market. Considering the rising drug-resistant infections, R&D for new vaccines and faster-acting drugs are on the rise, which drives the market during the forecast period.

Browse for Full Report Description@ https://www.omrglobal.com/industry-reports/tuberculosis-tb-therapeutics-market

Market Segmentation

Global Tuberculosis (TB) Therapeutics Market by Disease Type
Active TB
Latent TB
Global Tuberculosis (TB) Therapeutics Market by Therapy
First-Line Therapy
Second-Line Therapy
Regional Analysis

North America
United States
Canada
Europe
UK
Germany
Italy
Spain
France
Rest of Europe
Asia-Pacific
China
India
Japan
Rest of Asia-Pacific
Rest of the World
Company Profiles

Akorn Inc.
AstraZeneca Plc
Biochemical and Synthetic Products Pvt Ltd.
Eli Lilly & Co.
GlaxoSmithKline Plc
Johnson and Johnson Services Inc.
LabatecPharma SA
Lupin Ltd.
Macleods Pharmaceuticals Ltd.
Merck& Co. Inc.
Mylan N.V.
Novartis International AG
Otsuka Pharmaceutical Co. Ltd.
Pfizer Inc.
Sanofi SA
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/tuberculosis-tb-therapeutics-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwar

Email: [email protected]
Contact no: +91 780-304-0404